D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 48 Citations 10,923 80 World Ranking 2931 National Ranking 1384

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Virus

His primary areas of study are Immunology, Hepatitis C, Hepatitis C virus, Virology and Odds ratio. Jacquie Astemborski has researched Immunology in several fields, including Acquired immunodeficiency syndrome and Cocaine use. Hepatitis C is a primary field of his research addressed under Internal medicine.

The various areas that Jacquie Astemborski examines in his Hepatitis C virus study include Antibody and CD14. His biological study spans a wide range of topics, including RNA, Human leukocyte antigen and Frameshift mutation. His study looks at the relationship between Odds ratio and topics such as Incidence, which overlap with Risk factor, Pneumonia, Cause of death, First episode and Bacterial pneumonia.

His most cited work include:

  • HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection (1012 citations)
  • The Natural History of Hepatitis C Virus Infection: Host, Viral, and Environmental Factors (977 citations)
  • A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus (655 citations)

What are the main themes of his work throughout his whole career to date?

Jacquie Astemborski mainly investigates Immunology, Virology, Acquired immunodeficiency syndrome, Internal medicine and Hepatitis C virus. All of his Immunology and Viral disease, Virus, Sida, Viral load and Human leukocyte antigen investigations are sub-components of the entire Immunology study. The Virology study combines topics in areas such as Haplotype, Allele and Genotype.

The study incorporates disciplines such as Epidemiology, Proportional hazards model, Seroconversion, Cohort and Risk factor in addition to Acquired immunodeficiency syndrome. His Hepatitis C virus study integrates concerns from other disciplines, such as Liver disease, Hepatitis C, Antibody and Disease. His Liver disease research incorporates themes from Fibrosis and Cirrhosis.

He most often published in these fields:

  • Immunology (60.83%)
  • Virology (33.33%)
  • Acquired immunodeficiency syndrome (31.67%)

What were the highlights of his more recent work (between 2017-2021)?

  • Cohort (26.67%)
  • Acquired immunodeficiency syndrome (31.67%)
  • Cohort study (20.00%)

In recent papers he was focusing on the following fields of study:

Cohort, Acquired immunodeficiency syndrome, Cohort study, Internal medicine and Immunology are his primary areas of study. His work carried out in the field of Acquired immunodeficiency syndrome brings together such families of science as Harm reduction, Mental health and Virus. His Internal medicine study incorporates themes from Molecular epidemiology and Hepatitis C virus.

His Hepatitis C virus research integrates issues from Liver disease and Black race. His Immunology research is multidisciplinary, relying on both Methylation and Epigenetics. His Antibody research is multidisciplinary, incorporating perspectives in Drugs identified and Virology.

Between 2017 and 2021, his most popular works were:

  • Inhibitory killer cell immunoglobulin-like receptors strengthen CD8 + T cell-mediated control of HIV-1, HCV, and HTLV-1 (21 citations)
  • Reducing injection intensity is associated with decreased risk for invasive bacterial infection among high-frequency injection drug users (7 citations)
  • Recent fentanyl use among people who inject drugs: Results from a rapid assessment in Baltimore, Maryland (6 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Immune system

Jacquie Astemborski mostly deals with Heroin, Cohort, Harm reduction, Cohort study and Substance abuse. Jacquie Astemborski regularly links together related areas like Logistic regression in his Heroin studies. His studies deal with areas such as Hepatitis C virus, Fentanyl, Family medicine, Liver disease and Drug as well as Logistic regression.

His research on Cohort often connects related topics like Acquired immunodeficiency syndrome. His Acquired immunodeficiency syndrome study combines topics from a wide range of disciplines, such as Odds ratio, Endocarditis, Sepsis, Pneumonia and Internal medicine. His Cohort study research is multidisciplinary, incorporating elements of Cross-sectional study, Mortality rate, Recreational drug use, Emergency medicine and Polysubstance dependence.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The Natural History of Hepatitis C Virus Infection: Host, Viral, and Environmental Factors

David L. Thomas;Jacquie Astemborski;Rudra M. Rai;Frank A. Anania.
JAMA (2000)

1379 Citations

HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection

Salim I. Khakoo;Chloe L. Thio;Maureen P. Martin;Collin R. Brooks.
Science (2004)

1343 Citations

A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus

Ludmila Prokunina-Olsson;Brian Muchmore;Wei Tang;Ruth M Pfeiffer.
Nature Genetics (2013)

893 Citations

Initial Plasma HIV-1 RNA Levels and Progression to AIDS in Women and Men

Timothy R. Sterling;David Vlahov;David Vlahov;Jacquie Astemborski;Donald R. Hoover.
The New England Journal of Medicine (2001)

438 Citations

Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women.

Linda Ahdieh;Robert S. Klein;Robert Burk;Susan Cu-Uvin.
The Journal of Infectious Diseases (2001)

404 Citations

Limited Uptake of Hepatitis C Treatment Among Injection Drug Users

Shruti H. Mehta;Becky L. Genberg;Jacquie Astemborski;Ravi Kavasery.
Journal of Community Health (2008)

363 Citations

Human Immunodeficiency Virus-Related Microbial Translocation and Progression of Hepatitis C

Ashwin Balagopal;Frances H. Philp;Jacquie Astemborski;Timothy M. Block.
Gastroenterology (2008)

317 Citations

Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index.

Thomas B. Kelleher;Shruti H. Mehta;Ramakrishnan Bhaskar;Mark Sulkowski.
Journal of Hepatology (2005)

285 Citations

Sex Differences in Longitudinal Human Immunodeficiency Virus Type 1 RNA Levels among Seroconverters

Timothy R. Sterling;Timothy R. Sterling;Cynthia M. Lyles;David Vlahov;David Vlahov;David Vlahov;Jacquie Astemborski.
The Journal of Infectious Diseases (1999)

238 Citations

Racial Differences in HLA Class II Associations with Hepatitis C Virus Outcomes

Chloe L. Thio;David L. Thomas;James J. Goedert;David Vlahov;David Vlahov.
The Journal of Infectious Diseases (2001)

231 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Jacquie Astemborski

David L. Thomas

David L. Thomas

University College London

Publications: 122

David Vlahov

David Vlahov

Yale University

Publications: 100

Gregory J. Dore

Gregory J. Dore

University of New South Wales

Publications: 81

Shruti H. Mehta

Shruti H. Mehta

Johns Hopkins University

Publications: 79

Gregory D. Kirk

Gregory D. Kirk

Johns Hopkins University

Publications: 76

Jason Grebely

Jason Grebely

University of New South Wales

Publications: 66

Mary Carrington

Mary Carrington

Ragon Institute of MGH, MIT and Harvard

Publications: 63

Mark S. Sulkowski

Mark S. Sulkowski

Johns Hopkins University School of Medicine

Publications: 62

Margaret Hellard

Margaret Hellard

Burnet Institute

Publications: 55

Oliver Laeyendecker

Oliver Laeyendecker

National Institutes of Health

Publications: 52

Richard D. Moore

Richard D. Moore

Johns Hopkins University

Publications: 50

Thomas C. Quinn

Thomas C. Quinn

National Institutes of Health

Publications: 50

Michael P. Busch

Michael P. Busch

University of California, San Francisco

Publications: 43

Steffanie A. Strathdee

Steffanie A. Strathdee

University of California, San Diego

Publications: 43

Chloe L. Thio

Chloe L. Thio

Johns Hopkins University

Publications: 42

Peter Parham

Peter Parham

Stanford University

Publications: 41

Trending Scientists

Tim Oates

Tim Oates

University of Maryland, Baltimore County

Georges Zaccour

Georges Zaccour

HEC Montréal

David A. Maltz

David A. Maltz

Microsoft (United States)

Jianzhuang Xiao

Jianzhuang Xiao

Tongji University

Krishna D.P. Nigam

Krishna D.P. Nigam

Indian Institute of Technology Delhi

Jean Fischer

Jean Fischer

Centre national de la recherche scientifique, CNRS

Erik van der Linden

Erik van der Linden

Wageningen University & Research

Lisenka E.L.M. Vissers

Lisenka E.L.M. Vissers

Radboud University Nijmegen

Anne Dekinga

Anne Dekinga

Royal Netherlands Institute for Sea Research

Volker Heussler

Volker Heussler

University of Bern

Pertti Hari

Pertti Hari

University of Helsinki

Lois S. Weisman

Lois S. Weisman

University of Michigan–Ann Arbor

Robert N. Ginsburg

Robert N. Ginsburg

University of Miami

Thomas Becker

Thomas Becker

University of Edinburgh

David Back

David Back

University of Liverpool

Clive Barnett

Clive Barnett

University of Exeter

Something went wrong. Please try again later.